| Titolo |
Pubblicato in |
Anno |
| Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach |
MULTIPLE SCLEROSIS |
2024 |
| Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report |
NEUROLOGICAL SCIENCES |
2024 |
| Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease |
FRONTIERS IN NEUROLOGY |
2024 |
| Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis |
MICROORGANISMS |
2024 |
| Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy |
PATHOGENS |
2024 |
| Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7 |
THE CEREBELLUM |
2024 |
| Content Validity of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) Instrument in Spinocerebellar Ataxia |
THE CEREBELLUM |
2024 |
| Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias |
AMERICAN JOURNAL OF HUMAN GENETICS |
2023 |
| Multimodal Ophthalmic Imaging in Spinocerebellar Ataxia Type 7 |
LIFE |
2023 |
| The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review |
FRONTIERS IN IMMUNOLOGY |
2023 |
| Tominersen in Adults with Manifest Huntington's Disease |
THE NEW ENGLAND JOURNAL OF MEDICINE |
2023 |
| A clinical and epidemiological prevalence study on Friedreich’s Ataxia in Latium, Italy |
NEUROEPIDEMIOLOGY |
2022 |
| Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome |
SCIENTIFIC REPORTS |
2022 |
| Late-Onset MS: Disease Course and Safety-Efficacy of DMTS |
FRONTIERS IN NEUROLOGY |
2022 |
| Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease |
biorXiv |
2022 |
| CADASIL or MS? Consider “Red Flags” but Avoid a Misdiagnosis: Case Series of a Concomitant Diagnosis |
ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS |
2022 |
| CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review |
FRONTIERS IN NEUROLOGY |
2022 |
| Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment |
JOURNAL OF PERSONALIZED MEDICINE |
2022 |
| Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2022 |
